MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

Home » Inspire soars on Q1 sales projection

Inspire soars on Q1 sales projection

By

Inspire Medical Systems (NYSE:INSP) shares shot up more than 8% today on a first-quarter revenue projection of approximately $21.3 million, up 31% from the $16.3 million it pulled in during the first quarter of 2019.

Shares of INSP were up 8.2% at $68.61 per share in mid-afternoon trading today.

Inspire also withdrew its full-year guidance today in response to the ongoing COVID-19 pandemic. In February, the company said it expected full-year 2020 revenue to be in the range of $115 million to $119 million. As of March 31, 2020, the sleep apnea treatment developer had approximately $142 million in cash, cash equivalents and investments, down $14 million from the $156 million it held as of Dec. 31, 2019.

Inspire said it can’t predict the extent or duration of the impact coronavirus will have on financial results, but plans to provide more information during its first-quarter earnings call in May.

“The COVID-19 global health pandemic continues to cause meaningful complications to daily life and business operations,” Inspire president & CEO Tim Herbert said in the release. “The Inspire team is grateful to the healthcare professionals around the world who are selflessly caring for patients on the front lines of this pandemic, and our thoughts go out to all who have been affected.”

Inspire also announced the pricing of an underwritten public offering of 2 million shares of its common stock totaling approximately $116 million. The offering includes the shares of common stock priced at $58 per share, before underwriting discounts and commissions. Minneapolis-based Inspire also granted underwriters a 30-day option to purchase up to an additional 300,000 shares of common stock at the public offering price.

All shares are set to be sold by Inspire, which expects the offering to close on April 16, 2020, subject to closing conditions, according to a news release.

BofA Securities, J.P. Morgan and Goldman Sachs & Co. LLC are acting as joint book-running managers for the offering. Guggenheim Securities and SVB Leerink are acting as lead managers.

In case you missed it

RSS From Medical Design & Outsourcing

  • Steris stock downgraded as analysts expect lawyers to seek more ethylene oxide lawsuits
    Steris (NYSE: STE) stock was downgraded today by Needham from buy to hold following the $363 million jury verdict against its primary competitor, Sterigenics, over ethylene oxide (EtO) emissions. Needham analysts said they expect attorneys to target communities near EtO facilities with ads to find people willing to file more lawsuits against sterilization plant operators… […]
  • Researchers develop at-home device to track Parkinson’s progression
    Researchers at MIT and the University of Rochester Medical Center have developed a device to monitor a Parkinson’s patient at home. Collecting data at home could help provide a less subjective measurement than evaluations at the doctor’s office, which can be affected by outside factors. The technology could also help pharmaceutical and biotech companies developing… […]
  • Micro Mold renovates for new 5-axis milling center
    Precision mold maker Micro Mold has renovated in Erie, Pennsylvania, to make room for its new Yasda YMC650 high-speed 5-axis milling center and 3R Workpartner automation cell. The new equipment will be used for electrode manufacturing and finishing hard mill applications. The milling machine is accurate to 1 micron for high-volume, ultra-precision tooling work, the… […]
  • September 2022 Issue: The Medtech Big 100 is bigger than ever
    Medtech sales reach a record high as R&D spend and employee counts climb Supply Chain EVP Greg Smith sees fewer suppliers in Medtronic’s future Autotransfusion device maker ships units to Ukraine How IP protection is enabling robotic surgery innovation Connected device design for the real world: Managing the development process FDA details plans to expand… […]
  • How NeuroOne and Zimmer Biomet will partner on robotic brain surgery
    NeuroOne (NASDAQ: NMTC) is preparing its depth electrode technology for commercialization through Zimmer Biomet (NYSE: ZBH) while waiting for FDA feedback on its latest submission. NeuroOne’s Evo stereoelectroencephalography (sEEG) device won FDA 510(k) clearance in September 2021 for recording, monitoring, and stimulation of electrical signals at the subsurface level of the brain. That clearance was… […]
  • Trelleborg to show off advanced polymer tech at MD&M Minneapolis
    Trelleborg Healthcare & Medical will exhibit advanced polymer technologies for medical applications at MD&M Minneapolis, which runs Nov. 2–3, 2022. The Sweden-based engineering polymer giant, which has operations in 50 companies, has newly acquired, advanced capabilities in thermoplastic injection molding. The new injection molding capabilities come from its purchase of Menomonie, Wisconsin–based EirMed earlier this… […]
  • Millstone Medical Outsourcing expands cleanroom facility
    Millstone Medical Outsourcing said today that it has broken ground on a 5,000-square-foot cleanroom facility expansion at its Fall River, Massachusetts headquarters. The project is Millstone’s third cleanroom expansion. The additional Class 10,000/ISO7-rated cleanroom space is for medical device packaging operations. It will bring the company’s total cleanroom footprint to 20,000 square feet. Responding to… […]
  • Johnson & Johnson launches Bay Area science and technology campus
    Johnson & Johnson (NYSE:JNJ) has opened an almost 200,000 ft2 science and technology campus in the San Francisco Bay Area. The new facility more than doubles the presence of the company in the Bay Area, which has been a hub for life sciences innovation for decades. Up to 400 employees will work at the facility. “This… […]
  • VitalPath opens new Design Center in Minnesota
    VitalPath announced today that it recently opened a new Design Center in the Minneapolis suburb of New Hope. The Minnesota-based company manufactures custom, highly complex catheter solutions for major medical device companies. It says the new Design Center brings its entire design and prototyping capabilities under one roof in order to accelerate time to market.… […]
  • Currier Plastics buys building to expand capacity
    Currier Plastics has purchased a 71,000 ft² building to expand its capacity for healthcare customers. The Auburn, New York-based plastics manufacturer has already started building out the former TRW Automotive plant in Aurelius, New York. Construction is expected to be done in Q1 2023. The building will have 25,000 ft² of ISO Class 8 cleanroom… […]
  • Jury awards $363M verdict in Sterigenics ethylene oxide lawsuit
    An Illinois jury has awarded $363 million in a lawsuit that blamed a Sterigenics sterilization facility’s emissions of ethylene oxide for a woman’s breast cancer and her son’s non-Hodgkin’s lymphoma. It’s the first verdict in hundreds of lawsuits against Oak Brook, Illinois-based Sterigenics, which permanently closed the Willowbrook, Illinois facility in 2019 after state officials… […]